Jha et al.
845
Scheme 3. Synthethic route for the microwave-assisted reactions of compounds 1–12.
X
R
N
OH
+
OH
O
p-TSA, m.w.
+
HN
X
R
H
1-12
Procedure B (Scheme 3): A mixture of 2-naphthol
(10 mmol), appropriate aromatic aldehyde (12 mmol), p-
TSA (50 mg, cat.), and appropriate secondary amine
(12 mmol) was irradiated using the microwave for 1 min
(30 s × 2, to avoid overheating). The reaction mixture was
cooled and methanol was added to it. Several products, viz.
compounds 1, 3, 5, 6, and 8, were purified by digestion in
methanol as follows. The reaction mixture was stirred in hot
methanol (20 mL) for 1 h and kept at room temperature
overnight for crystallization and precipitation. The solid
product was filtered, washed with cold methanol (2 × 5 mL),
and dried under vacuum. The rest of the derivatives were pu-
rified by column chromatography using silica gel. The de-
sired product eluted with 2% ethyl acetate in hexanes. The
products thus obtained were further purified by crystalliza-
tion.
7.18–7.31 (2H, m, Ar-H), 7.42 (1H, t, J= 7.5 Hz, Ar-H),
7.70–7.81 (5H, m, Ar-H), 8.13–8.16 (2H, m, Ar-H), 13.78
(1H, bs, OH). 13C NMR (75 MHz, 273 K, CDCl3) δ: 24.32,
26.10, 26.40, 52.78, 55.03, 71.45, 115.26, 120.48, 120.83,
123.22, 124.61, 127.26, 129.06, 129.61, 130.21, 130.62,
132.33, 147.61, 147.73, 155.74. EI-MS (70 eV) m/z (% int.):
362 (M+, 14), 279 (9), 260 (61), 231 (39), 230 (100), 85
(54), 58 (14). HR-MS calcd. for C22H22N2O3: 362.1630;
found: 362.1634.
1-(2-Nitrophenyl)piperidin-1-ylmethyl)naphthalen-2-ol (4)
UV–vis (MeOH, nm) λmax: 241, 335. IR (KBr disc, cm–1)
ν: 3439, 3052, 2926, 1621, 1595, 1514, 1316, 1265, 1231,
830. 1H NMR (500 MHz, 273 K, CDCl3) δ: 1.25–1.32
(1H, m, CH), 1.67–1.77 (5H, m, 5 × CH), 2.35–2.38 (2H, m,
2 × NCH), 2.58 (1H, d, J = 9.5 Hz, NCH), 3.30 (1H, d, J =
11.5 Hz, NCH), 6.08 (1H, s, Ar-CH-Ar′), 7.15 (1H, d, J =
9.0 Hz, Ar-H), 7.21–7.26 (1H, m, Ar-H), 7.31–7.45 (3H, m,
Ar-H), 7.65–7.71 (3H, m, Ar-H), 7.81–7.85 (2H, m, Ar-H),
14.54 (1H, bs, OH). 13C NMR (125 MHz, 273 K, CDCl3) δ:
23.90, 25.93, 26.52, 49.92, 54.62, 64.02, 115.07, 120.20,
120.64, 122.69, 124.29, 126.97, 128.58, 128.86, 128.93,
130.09, 131.55, 132.61, 133.65, 133.70, 150.22, 156.94. EI-
MS (70 eV) m/z (% int.): 362 (M+, 2), 231 (100), 232 (47),
85 (3). HR-MS calcd. for C23H23NO3: 362.1630; found:
362.1633.
1-(Phenylpiperidin-1-ylmethyl)naphthalen-2-ol (1)
1H and 13C NMR were identical to those reported in the
literature (27). UV–vis (MeOH, nm) λmax: 244, 280, 336. IR
(KBr disc, cm–1) ν: 3443, 3050, 2971, 1621, 1599, 1455,
1268, 1238, 702. EI-MS (70 eV) m/z (% int.): 317 (M+, 11),
231 (100), 200 (2), 84 (41). HR-MS calcd. for C22H23NO:
317.1780; found: 317.1785.
1-(4-Methylphenyl)piperidin-1-ylmethyl)naphthalen-2-ol
(2)
UV–vis (MeOH, nm) λmax: 244, 291, 336. IR (KBr
1-(4-Chlorophenyl)piperidin-1-ylmethyl)naphthalen-2-ol
(5)
disc, cm–1) ν: 3439, 3060, 2963, 1621, 1595, 1384, 1359,
1
1261, 1231, 821. H NMR (300 MHz, 273 K, CDCl3) δ:
UV–vis (MeOH, nm) λ max: 242, 291, 336. IR (KBr
disc, cm–1) ν: 3440, 3080, 2951, 1620, 1519, 1474, 1384,
1.41 (1H, bs, CH), 1.50–1.91 (5H, m, 5 × CH), 2.27–2.46
(4H, m, Ar-CH3, NCH), 2.92 (1H, bs, NCH), 3.23 (1H, bs,
NCH), 3.53 (1H, bs, NCH), 5.23 (1H, s, Ar-CH-Ar′), 7.01–
7.08 (1H, m, Ar-H), 7.22–7.28 (2H, m, Ar-H), 7.37–7.42
(3H, m, Ar-H), 7.49–7.52 (2H, m, Ar-H), 7.68–7.73 (1H, m,
Ar-H), 7.81–7.84 (1H, m, Ar-H), 13.32 (1H, bs, OH). 13C
NMR (75 MHz, 273 K, CDCl3) δ: 21.63, 24.03, 25.72,
26.00, 52.10, 55.20, 64.90, 109.00, 117.82, 120.33, 121.24,
123.06, 126.22, 127.10, 129.11, 129.47, 130.25, 130.87,
134.88, 155.36. EI-MS (70 eV) m/z (% int.): 331 (M+, 14),
247 (10), 231 (100). HR-MS calcd. for C23H25NO:
331.1936; found: 331.1930.
1
1104, 742, 515. H NMR (300 MHz, 273 K, CDCl3) δ: 1.27
(1H, bs, CH), 1.62–1.70 (5H, bs, 5 × CH), 1.97 (1H, bs,
NCH), 2.03 (1H, bs, NCH), 2.73 (1H, bs, NCH), 3.36 (1H,
bs, NCH), 5.07 (1H, s, Ar-CH-Ar′), 7.19–7.41 (4H, m, Ar-
H), 7.43–7.46 (1H, m, Ar-H), 7.54–7.68 (2H, m, Ar-H),
7.71–7.81 (3H, m, Ar-H), 3.12 (1H, bs, OH). 13C NMR
(75 MHz, 273 K, CDCl3) δ: 24.35, 26.10, 26.30, 52.41,
55.14, 71.49, 117.13, 120.45, 121.20, 123.06, 127.08,
129.51, 129.77, 130.22 130.94, 131.16, 132.50, 134.21,
138.33, 156.12. EI-MS (70 eV) m/z (% int.): 353 (M + 2,
0.7), 350 (M+, 2), 266 (2), 264 (2), 231 (6), 84 (100). HR-
MS calcd. for C22H22ClNO: 351.1390; found: 351.1387.
1-(4-Nitrophenyl)piperidin-1-ylmethyl)naphthalen-2-ol (3)
UV–vis (MeOH, nm) λmax: 244, 295, 335. IR (KBr
disc, cm–1) ν: 3439, 3080, 3060, 2926, 1621, 1514, 1441,
1-(Piperidin-1-yl-pyridin-4-ylmethyl)naphthalen-2-ol (6)
UV–vis (MeOH, nm) λmax: 241, 298. IR (KBr disc, cm–1)
ν: 3442, 3044, 2944, 1621, 1598, 1451, 1384, 1267, 1236,
1
1414, 1346, 1265, 1231, 830. H NMR (300 MHz, 273 K,
1
CDCl3) δ: 1.28 (1H, bs, CH), 1.58–1.73 (5H, m, 5 × CH),
2.02 (1H, bs, -NCH), 2.15 (1H, bs, -NCH), 2.65 (1H, bs,
-NCH), 3.37 (1H, bs, -NCH), 5.23 (1H, s, Ar-CH-Ar′),
816. H NMR (300 MHz, 273 K, CDCl3) δ: 1.61 (1H, bs,
CH), 1.72–1.88 (5H, bs, 5 × CH), 2.10 (1H, bs, -NCH), 2.71
(1H, bs, -NCH), 3.16 (1H, bs, -NCH), 3.35 (1H, bs, -NCH),
© 2006 NRC Canada